menu title
MWAETC On-Demand: Presentation Center
Welcome to the MWAETC On-Demand Presentation Center. Please use the following search tools or navigate by category to find presentations and other multimedia related to the ongoing care of HIV/AIDS. Please note: The content in these presentations are those of the presenters(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, the U.S. Government, or the MWAETC.
The Future of ART: Two-Drug Oral and Injectable Therapy
The Future of ART: Two-Drug Oral and Injectable Therapy
• Discuss the future of antiretroviral therapy, which prioritizes two-drug options (and gather opinions on benefits vs. drawbacks of two-drug HIV treatment).
• Explain the newest data and developments in long-acting antiretroviral therapy and evolutions in our understanding of who may benefit from this therapy.
• Describe novel antiretroviral medications that are in development and likely coming in the near future.
Presented by:
Brian Wood, MD
Professor, Department of Medicine,
Division of Allergy & Infectious Diseases
Medical Director, MWAETC HIV ECHO Program
Associate Editor for the National HIV Curriculum and
National HIV PrEP Curriculum
University of Washington
Recently Added
-
-
Recommendations for PEP in Healthcare Settings
-
HIV treatment and prevention studies presented at the IDWeek conference
-
Hot Topics:
-
Key Components of Care Models for Older People with HIV
-
Injectable lenacapavir for pre-exposure prophylaxis
-
Considerations for measles infection and vaccination in PWH
-
Research and recommendations for injectable ART
HIV Prevention
-
Recommendations for PEP in Healthcare Settings
-
Injectable lenacapavir for pre-exposure prophylaxis
-
Local and national guidelines on nPEP for HIV Prevention
-
Review of PURPOSE Trials Studying Use of Lenacapavir for PrEP
HIV Treatment
-
-
ART Resistance Tests & the Stanford HIV Drug Resistance Database
-
Research and recommendations for injectable ART
-
Latest data on abacavir for ART
Guidelines
-
September 2025 HHS Guidelines Updates
-
Updates on tuberculosis treatment and prevention for PWH
-
2025 CDC Recommendations for nPEP
-
Updated IAS-USA Guidelines on PrEP
Common Co-Occurring Conditions
-
-
-
-
Prevention and intervention for cognitive impairment in PWH
Socio-Behavioral
-
Mental health considerations for older persons with HIV
-
Policies and case studies of HIV-related criminal laws
Key Populations
-
Key Components of Care Models for Older People with HIV
-
Part 3 of the 4Ms framework
-
-
Models of Care
-
Part Two of Discussion of Regulatory Changes in OUD Treatment Programs
-
Telehealth to facilitate diagnosis and treatment of HIV for incarcerated…
-
Innovative HIV health care service delivery
-
An approach to engage people with HIV who are not currently in care
Conference Updates
-
HIV treatment and prevention studies presented at the IDWeek conference
-
IAS Conference update on PrEP for HIV Prevention
-
-
Review of abstracts presented at CROI 2025
